Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Dividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Growth Metrics
Income Statement
Others
Ratios

Pharma-Bio Serv (PBSV) Amortizatization of Intangibles (2023 - 2025)

Historic Amortizatization of Intangibles for Pharma-Bio Serv (PBSV) over the last 3 years, with Q4 2025 value amounting to $43359.0.

  • Pharma-Bio Serv's Amortizatization of Intangibles rose 683.24% to $43359.0 in Q4 2025 from the same period last year, while for Oct 2025 it was $169209.0, marking a year-over-year increase of 719.4%. This contributed to the annual value of $169209.0 for FY2025, which is 719.4% up from last year.
  • According to the latest figures from Q4 2025, Pharma-Bio Serv's Amortizatization of Intangibles is $43359.0, which was up 683.24% from $42512.0 recorded in Q3 2025.
  • In the past 5 years, Pharma-Bio Serv's Amortizatization of Intangibles ranged from a high of $43359.0 in Q4 2025 and a low of $35431.0 during Q1 2023
  • Over the past 3 years, Pharma-Bio Serv's median Amortizatization of Intangibles value was $39488.0 (recorded in 2024), while the average stood at $39441.4.
  • Within the past 5 years, the most significant YoY rise in Pharma-Bio Serv's Amortizatization of Intangibles was 808.28% (2025), while the steepest drop was 679.8% (2025).
  • Quarter analysis of 3 years shows Pharma-Bio Serv's Amortizatization of Intangibles stood at $37553.0 in 2023, then rose by 8.08% to $40586.0 in 2024, then increased by 6.83% to $43359.0 in 2025.
  • Its Amortizatization of Intangibles was $43359.0 in Q4 2025, compared to $42512.0 in Q3 2025 and $41952.0 in Q2 2025.